# EDGAR Filing Document

**Accession Number:** 0001255051
**File Stem:** 0000006281-23-000069
**Filing Date:** 2023-3
**Character Count:** 14381
**Document Hash:** e6daee2525660014fe3d57bc22ca97b1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000006281-23-000069.hdr.sgml**: 20230310

**ACCESSION NUMBER**: 0000006281-23-000069

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 4

**CONFORMED PERIOD OF REPORT**: 20230308

**FILED AS OF DATE**: 20230310

**DATE AS OF CHANGE**: 20230310

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** GLIMCHER LAURIE H M.D.
- **CENTRAL INDEX KEY:** 0001255051

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07819
- **FILM NUMBER:** 23725008

**MAIL ADDRESS:**
- **STREET 1:** WEILL CORNELL MED COLLEGE, CORNELL UNIV
- **STREET 2:** 1300 YORK AVENUE, F-113
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10065

**FORMER NAME:**
- **FORMER CONFORMED NAME:** GLIMEHER LAURIE H
- **DATE OF NAME CHANGE:** 20030717
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ANALOG DEVICES INC
- **CENTRAL INDEX KEY:** 0000006281
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **IRS NUMBER:** 042348234
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1028

**BUSINESS ADDRESS:**
- **STREET 1:** ONE ANALOG WAY
- **CITY:** WILMINGTON
- **STATE:** MA
- **ZIP:** 01887
- **BUSINESS PHONE:** 7813294700

**MAIL ADDRESS:**
- **STREET 1:** ONE ANALOG WAY
- **CITY:** WILMINGTON
- **STATE:** MA
- **ZIP:** 01887

## Ex-24

```
<pre>
SUBSTITUTE POWER OF ATTORNEY

      Pursuant to a written Limited Power of Attorney for Section 16 Reporting Obligations granted by each of the following individuals (collectively, the "Powers of Attorney"), copies of which were previously filed with the Securities and Exchange Commission, the undersigned has been constituted and appointed true and lawful attorney-in-fact and agent, with full powers of substitution and revocation, to do and perform every act and thing whatsoever requisite, necessary or proper to be done in the exercise of the rights and powers granted in such Powers of Attorney:
      James A. Champy
      Anantha P. Chandrakasan
      Martin Cotter
      Bruce R. Evans
      Edward H. Frank
      Laurie H. Glimcher
      Karen M. Golz
      Joseph Hassett
      Gregory N. Henderson
      Mark M. Little
      Prashanth Mahendra-Rajah
      Steve Pietkiewicz
      Vincent Roche
      Kenton J. Sicchitano
      Ray Stata

      The undersigned, pursuant to the powers granted in the Powers of Attorney, hereby constitutes and appoints Eric French as substitute to the undersigned attorney-in-fact, with full power and authority to do and perform every act and thing whatsoever requisite, necessary or proper to be done in the exercise of the rights and powers granted to the undersigned in the Powers of Attorney.  For the avoidance of doubt, the foregoing appointment shall not serve as a revocation of the powers granted to the undersigned in the Powers of Attorney.
      This Substitute Power of Attorney shall remain in full force and effect with respect to each individual listed above, until the underlying Power of Attorney is revoked or terminated, unless earlier revoked by the undersigned in a signed writing.

IN WITNESS WHEREOF, the undersigned has caused this Substitute Power of Attorney to be executed as of this 19th day of January, 2021.

/s/ Margaret K. Seif
Signature

Margaret K. Seif
Print Name

\\\DC - 57385/2 - #1301253 v1

\\\DC - 57385/2 - #1301253 v1

</pre>
```

## Ex-24

```
<pre>
LIMITED POWER OF ATTORNEY
FOR SECTION 16 REPORTING OBLIGATIONS

       Know all by these presents, that the undersigned hereby makes, constitutes and appoints each of
Yoon Ah Oh, Margaret Seif, Jeanne Weinzierl, and Karen Maloney, signing singly and each acting
individually, as the undersigned's true and lawful attorney-in-fact with full power and authority as
hereinafter described to:
       (1)    prepare, execute and file on behalf of the undersigned Form ID in order to obtain access
codes for the undersigned to permit filing on EDGAR;
       (2)    prepare, execute and file on behalf of the undersigned all Forms 3, 4 and 5 (including any
amendments thereto) that the undersigned may be required to file with the United States Securities and
Exchange Commission as a result of the undersigned's ownership of or transactions in securities of
Analog Devices, Inc. (the "Company"), in accordance with Section 16(a) of the Securities Exchange Act
of 1934 and the rules thereunder (the "Exchange Act");
       (3)    seek or obtain, as the undersigned's representative and on the undersigned's behalf,
information regarding transactions in the Company's securities from any third party, including brokers,
employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person
to release any such information to such attorney-in-fact and approves and ratifies any such release of
information; and
       (4)    take any other action of any type whatsoever in connection with the foregoing which, in
the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
       The undersigned hereby grants to each such attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned
might or could do if personally present, with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully
do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request
of the undersigned, are not assuming or relieving, nor is the Company assuming or relieving, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.  The undersigned
acknowledges that neither the Company nor the foregoing attorneys-in-fact assume (i) any liability for the
undersigned's responsibility to comply with the requirement of the Exchange Act, (ii) any liability of the
undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the
undersigned for profit disgorgement under Section 16(b) of the Exchange Act.
       This Power of Attorney shall remain in full force and effect until the undersigned is no longer
required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.
       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as
of this 24th day of August, 2020.

/s/ Laurie Glimcher
Laurie Glimcher

\\\DC - 57385/2 - #1301253 v1

\\\DC - 57385/2 - #1301253 v1
</pre>
```

## Ex-24

```
<pre>
SUBSTITUTE POWER OF ATTORNEY

      Pursuant to a written Limited Power of Attorney for Section 16 Reporting Obligations granted by each of the following individuals (collectively, the "Powers of Attorney"), copies of which were previously filed with the Securities and Exchange Commission, the undersigned has been constituted and appointed true and lawful attorney-in-fact and agent, with full powers of substitution and revocation, to do and perform every act and thing whatsoever requisite, necessary or proper to be done in the exercise of the rights and powers granted in such Powers of Attorney:
      James A. Champy
      Anantha P. Chandrakasan
      Martin Cotter
      Tunc Doluca
      Bruce R. Evans
      Edward H. Frank
      Laurie H. Glimcher
      Karen M. Golz
      Gregory N. Henderson
      Mercedes Johnson
      Mark M. Little
      Prashanth Mahendra-Rajah
      Vincent Roche
      Anelise Angelino Sacks
      Kenton J. Sicchitano
      Ray Stata

      The undersigned, pursuant to the powers granted in the Powers of Attorney, hereby constitutes and appoints Janene Asgeirsson and Shelly Shaw as substitute to the undersigned attorney-in-fact, with full power and authority to do and perform every act and thing whatsoever requisite, necessary or proper to be done in the exercise of the rights and powers granted to the undersigned in the Powers of Attorney.  For the avoidance of doubt, the foregoing appointment shall not serve as a revocation of the powers granted to the undersigned in the Powers of Attorney.
      This Substitute Power of Attorney shall remain in full force and effect with respect to each individual listed above, until the underlying Power of Attorney is revoked or terminated, unless earlier revoked by the undersigned in a signed writing.

IN WITNESS WHEREOF, the undersigned has caused this Substitute Power of Attorney to be executed as of this 3rd day of March, 2022.

Signature

/s/ Margaret K. Seif
Print Name

\\\DC - 57385/2 - #1301253 v1

\\\DC - 57385/2 - #1301253 v1

</pre>
```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>GLIMCHER LAURIE H M.D.<br><sub>(Last) (First) (Middle)</sub><br><br>ONE ANALOG WAY<br><sub>(Street)</sub><br>WILMINGTON, MA 01887<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-08 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>ANALOG DEVICES INC [ ADI ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Comm Stock - $.16-2/3 value | 2023-03-08 |  | M |  | 1495 | A | $0 | 3530 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Unit (RSU) | $0.0 | 2023-03-08 |  | A |  | 1228 |  | <sup>(1)</sup> | <sup>(1)</sup> | Comm Stock - $.16-2/3 value | 1228.0 | $0 | 1228 | D |  |
| Restricted Stock Unit (RSU) | $0.0 | 2023-03-08 |  | M |  |  | 1495 | <sup>(2)</sup> | <sup>(2)</sup> | Comm Stock - $.16-2/3 value | 1495.0 | $0 | 0 | D |  |

---

### Footnotes:

(1) This RSU vests 100% on the earlier of March 8, 2024 or the date of the Company's next Annual Meeting of Shareholders. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company.

(2) In accordance with the terms of the grant, this RSU vested 100% on March 8, 2023, the date of the Company's 2023 Annual Meeting of Shareholders.  Upon the vesting date, each vested RSU automatically converted into one (1) share of common stock of the Company.

**Signature:** /s/ Shelly Shaw, Associate General Counsel, by Power of Attorney  
**Date:** 2023-03-10

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**